New Inhibitors of Glucose-6-Phosphate Dehydrogenase Discovered by Molecular Docking

Authors

  • Haitham Al-Madhagi Biochemical Technology Program, Faculty of Applied Sciences, Thamar University
  • Hisham Al-Ward Shanghai Institute of Stem Cell Research and Clinical Translation, School of Medicine, Tongji University

DOI:

https://doi.org/10.55927/eajmr.v1i9.1191

Keywords:

Virtual Screening, Molecular Docking, G6PD, 6-Aminonicotinamide, ADME

Abstract

The aim of this study is to in silico screen new glucose-6-phosphate dehydrogenase (G6PD) inhibitors. glucose-6-phosphate dehydrogenase is the first and regulator of pentose phosphate pathway providing NADPH and ribose-5-phosphate required for various syntheses from fatty acids to DNA. G6PD is linked to oxidative stress and hence, to inflammation as well. Therefore, G6PD inhibition is a useful target against inflammation, cancer and some infections. Virtual screening of 15 ligands in the NADP-binding site in comparison with the standard inhibitor 6-aminonicotinamide using iGEMDOCK. Besides, ADME properties of the selected compounds were performed via SWISSADME webserver. All the tested ligands were better than reference inhibitor in terms of binding energy as well as pharmacokinetic and ADME parameters. Moreover, of all tested compounds, ligand 15 showed best docking fitness (-115 Kcal/mole total energy). Novel compounds were screened to be lead inhibitors of G6PD enzyme and ligand 15 ranked first.

References

Au, S.W., Gover, S., Lam, V.M., Adams, M.J., 2000. Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency. Structure 8, 293–303.

Berneburg, I., Peddibhotla, S., Heimsch, K.C., Haeussler, K., Maloney, P., Gosalia, P., Preuss, J., Rahbari, M., Skorokhod, O., Valente, E., 2022. An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6 Phosphogluconolactonase. Antimicrobial Agents and Chemotherapy e02109–21.

Chen, X., Xu, Z., Zhu, Z., Chen, A., Fu, G., Wang, Y., Pan, H., Jin, B., 2018. Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro. International journal of oncology 53, 1703–1712.

Chhabra, A., Mishra, S., Kumar, G., Gupta, A., Keshri, G.K., Bharti, B., Meena, R.N., Prabhakar, A.K., Singh, D.K., Bhargava, K., 2018. Glucose-6-phosphate dehydrogenase is critical for suppression of cardiac hypertrophy by H2S. Cell death discovery 4, 1–16.

Daina, A., Michielin, O., Zoete, V., 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports 7, 1–13.

Hsu, K.-C., Chen, Y.-F., Lin, S.-R., Yang, J.-M., 2011. iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC bioinformatics 12, 1–11.

Hutchings, D., Rawsthorne, S., Emes, M.J., 2005. Fatty acid synthesis and the oxidative pentose phosphate pathway in developing embryos of oilseed rape (Brassica napus L.). Journal of Experimental Botany 56, 577–585.

Köhler, E., Barrach, H.-J., Neubert, D., 1970. Inhibition of NADP dependent oxidoreductases by the 6 aminonicotinamide analogue of NADP. FEBS letters 6, 225–228.

Koperniku, A., Garcia, A.A., Mochly-Rosen, D., 2022. Boosting the Discovery of Small Molecule Inhibitors of Glucose-6-Phosphate Dehydrogenase for the Treatment of Cancer, Infectious Diseases, and Inflammation. Journal of Medicinal Chemistry 65, 4403–4423.

Kotaka, M., Gover, S., Vandeputte-Rutten, L., Au, S.W.N., Lam, V.M.S., Adams, M.J., 2005. Structural studies of glucose-6-phosphate and NADP + binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr 61, 495–504. https://doi.org/10.1107/S0907444905002350

Li, R., Wang, W., Yang, Y., Gu, C., 2020. Exploring the role of glucose-6 phosphate dehydrogenase in cancer. Oncology Reports 44, 2325–2336.

O’Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., Hutchison, G.R., 2011. Open Babel: An open chemical toolbox. Journal of cheminformatics 3, 1–14.

Stanton, R.C., 2012. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB life 64, 362–369.

Tang, B.L., 2019. Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway. Journal of Cellular Biochemistry 120, 14285–14295.

Tian, W.-N., Braunstein, L.D., Pang, J., Stuhlmeier, K.M., Xi, Q.-C., Tian, X., Stanton, R.C., 1998. Importance of glucose-6 phosphate dehydrogenase activity for cell growth. Journal of Biological Chemistry 273, 10609–10617.

Yang, H.-C., Wu, Y.-H., Liu, H.-Y., Stern, A., Chiu, D.T.-Y., 2016. What has passed is prolog: new cellular and physiological roles of G6PD. Free radical research 50, 1047–1064.

Downloads

Published

2022-10-29

How to Cite

Haitham Al-Madhagi, & Hisham Al-Ward. (2022). New Inhibitors of Glucose-6-Phosphate Dehydrogenase Discovered by Molecular Docking. East Asian Journal of Multidisciplinary Research, 1(9), 1793–1800. https://doi.org/10.55927/eajmr.v1i9.1191